A Research Study On Gene Therapy

1089 Words5 Pages
The book talks about how upcoming trends in gene and cell therapy is meant for those who look for the valuable thread that runs through the arena of gene therapy, cell therapy, and tissue engineering, yet found other sources too specialized to undertake it. This book focuses on arming basic clinicians and scientists with this valuable thread so that they are better situated to tackle the weakening diseases currently plaguing mankind. The authors argue that gene and cell therapies are promising policies for managing acquired and genetic illnesses. Currently, various ethical issues and biological barriers have restricted their clinical interpretation. This book is important in informing the audience on the currently position of gene therapy especially to experts who are trying to ensure that gene therapy becomes successful. Being successful involves it being in a position to help people who are struggling with acquired or inherited diseases. It will help me build my argument in the reason why gene therapy has not received the much expected attention. The book also offers an insight on what gene therapy is all about so it can serve as a very good introduction. Johnson, Carolyn Y. & Brady, Dennis. Gene therapies offer dramatic promise but shocking costs. November 11th, 2015. Retrieved from: http://www.geneticsandsociety.org/article.php?id=8981 This article offers an insight into the possible reasons why gene therapy has not gained acceptance has was initially expected. According to the authors, gene therapy is one of the most costly treatments which few people can afford. This mode of treatment was approved in 2012 in Europe and costs about 1 million dollars, and prices are projected to be the same in the US. The author claims that... ... middle of paper ... ...netic improvements. For instance, HGH, which prior to 1985 could be attained only in restricted quantities from cadaveric pituitary glands, now can be generated using recombinant DNA technique. If the supply of genetic drugs were more restricted, HGH was set for children with short physique brought about by standard growth hormone inefficiency. Nonetheless, with the introduction of recombinant DNA generation, more doctors have started suggesting use of HGH for non-hormone-deficient kids who are not within the normal range. This article is very relevant to my paper because it touches on the ethical and regulatory issues that may be affecting the acceptance of genetic treatment. I will use this article to argue that some people may be questioning the ethical codes and regulatory policies which may be making them accepting genetic therapy slower than it was anticipated.
Open Document